EMAIL THIS PAGE TO A FRIEND

Journal of virology

Serotonin Receptor Agonist 5-Nonyloxytryptamine Alters the Kinetics of Reovirus Cell Entry.


PMID 26109733

Abstract

Mammalian orthoreoviruses (reoviruses) are nonenveloped double-stranded RNA viruses that infect most mammalian species, including humans. Reovirus binds to cell surface glycans, junctional adhesion molecule A (JAM-A), and the Nogo-1 receptor (depending on the cell type) and enters cells by receptor-mediated endocytosis. Within the endocytic compartment, reovirus undergoes stepwise disassembly, which is followed by release of the transcriptionally active viral core into the cytoplasm. In a small-molecule screen to identify host mediators of reovirus infection, we found that treatment of cells with 5-nonyloxytryptamine (5-NT), a prototype serotonin receptor agonist, diminished reovirus cytotoxicity. 5-NT also blocked reovirus infection. In contrast, treatment of cells with methiothepin mesylate, a serotonin antagonist, enhanced infection by reovirus. 5-NT did not alter cell surface expression of JAM-A or attachment of reovirus to cells. However, 5-NT altered the distribution of early endosomes with a concomitant impairment of reovirus transit to late endosomes and a delay in reovirus disassembly. Consistent with an inhibition of viral disassembly, 5-NT treatment did not alter infection by in vitro-generated infectious subvirion particles, which bind to JAM-A but bypass a requirement for proteolytic uncoating in endosomes to infect cells. We also found that treatment of cells with 5-NT decreased the infectivity of alphavirus chikungunya virus and coronavirus mouse hepatitis virus. These data suggest that serotonin receptor signaling influences cellular activities that regulate entry of diverse virus families and provides a new, potentially broad-spectrum target for antiviral drug development. Identification of well-characterized small molecules that modulate viral infection can accelerate development of antiviral therapeutics while also providing new tools to increase our understanding of the cellular processes that underlie virus-mediated cell injury. We conducted a small-molecule screen to identify compounds capable of inhibiting cytotoxicity caused by reovirus, a prototype double-stranded RNA virus. We found that 5-nonyloxytryptamine (5-NT) impairs reovirus infection by altering viral transport during cell entry. Remarkably, 5-NT also inhibits infection by an alphavirus and a coronavirus. The antiviral properties of 5-NT suggest that serotonin receptor signaling is an important regulator of infection by diverse virus families and illuminate a potential new drug target.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

A9434
Ammonium chloride, for molecular biology, suitable for cell culture, ≥99.5%
H4ClN
09718
Ammonium chloride, BioUltra, for molecular biology, ≥99.5% (AT)
H4ClN
254134
Ammonium chloride, 99.998% trace metals basis
H4ClN
326372
Ammonium chloride, 99.99% trace metals basis
H4ClN
G5417
Glycine, PharmaGrade, Ajinomoto, EP, JP, USP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture
C2H5NO2
410225
Glycine, ACS reagent, ≥98.5%
C2H5NO2
G7126
Glycine, ReagentPlus®, ≥99% (HPLC)
C2H5NO2
50046
Glycine, BioUltra, for molecular biology, ≥99.0% (NT)
C2H5NO2
G8898
Glycine, for electrophoresis, ≥99%
C2H5NO2
G7403
Glycine, BioXtra, ≥99% (titration)
C2H5NO2
G8790
Glycine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, ≥98.5%
C2H5NO2
W328707
Glycine, 99%, FCC
C2H5NO2
11317
Methanesulfonic acid, PharmaGrade, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production
CH4O3S
471356
Methanesulfonic acid, ≥99.0%
CH4O3S
M4141
Methanesulfonic acid solution, 4 M (with 0.2% (w/v) tryptamine)
CH4O3S
471348
Methanesulfonic acid solution, 70 wt. % in H2O
CH4O3S
792500
Sodium pyruvate, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99%
C3H3NaO3
80443
Sodium pyruvate, PharmaGrade, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production.
C3H3NaO3
P2256
Sodium pyruvate, ReagentPlus®, ≥99%
C3H3NaO3
P8574
Sodium pyruvate, BioXtra, ≥99%
C3H3NaO3
P5280
Sodium pyruvate, powder, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥99%
C3H3NaO3
P4562
Sodium pyruvate, powder, BioXtra, suitable for mouse embryo
C3H3NaO3
P3662
Sodium pyruvate, Hybri-Max, powder, suitable for hybridoma
C3H3NaO3